Our Co-Founder and CSO Caroline Benn spoke with Eva Haas of Optimum Strategic Communications for an episode of the Optimum Perspectives podcast.

Caroline reflected on her journey and motivations in becoming a scientist and researcher, and what fuelled her passion to focus on Huntington’s disease and eventually co-founding LoQus23 Therapeutics with CEO David Reynolds.

She also delves into the disease pathology and genetic basis of Huntington’s disease – a devastating disease for which there is currently no effective treatment.

Listen to the full conversation linked here: Optimum Perspectives Podcast – Optimum Strategic Communications